BioBunBan Joins 紳太 International Health Integrator to Accelerate Entry into International Markets

BioBunBan's strategy encompasses the development of products aligned with global market demands and the expansion of distribution channels. Additionally, the company has entered into a memorandum of understanding with 紳太International Health Integration, aiming to expedite the scale-up and international market entry process.

Mr. Lo Ho Chin, R&D Director, introduced the company structure to the audience on the stage.

General Manager Mr. Yang Zheng participated in the signing ceremony.

The 紳太International Health Integrator offers a distinctive approach to business incubation and acceleration. Unlike traditional incubators and accelerators, it focuses on a select group of 1-100 start-ups, providing tailored coaching to support their growth and expansion into international markets. The Integrator is staffed by a group of experienced professionals from various industries who provide market-valuable, specialised, and precise coaching with the expectation of scaling up the team to achieve maximum potential. The fusion of international market trends, market demand-driven strategies, branding channels, revenue and cost integration, and cross-disciplinary integration of start-ups into the greatest cohesion helps start-ups expand profits as soon as possible, creating a win-win situation for both founders and investors. Providing comprehensive support will assist Taiwanese AI and biomedical health start-ups in expanding their international market presence and navigating the challenges of the real market environment. This will enable them to establish an efficient, time-saving and mutually beneficial win-win industrial ecosystem.

Source: https://money.udn.com/money/story/11799/8053879